APRE vs STZ · $10.4M cap vs P/E 14, rev $9.14B
Aprea Therapeutics Inc (APRE) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
APRE does not have a complete income-statement cache yet.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
APRE currently screens at market cap $10.4M. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the APRE and STZ stock pages for the full models.
Not investment advice.